The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia; and spherical lense, including lenses that correct near and farsightedness in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including paragard contraceptive intrauterine devices; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

The Cooper Companies, Inc.

Shares of The Cooper Companies ($COO) are in focus after activist investor Jana Partners called for significant changes at the medical-device compa...

Jana Partners Pushes Cooper to Replace CEO, Explore Contact-Lens Business Sale

In a report released today, Jonathan Block from Stifel Nicolaus maintained a Buy rating on Cooper Co, with a price target of $70.00. According to T...

Cooper Co (COO) Receives a Buy from Stifel Nicolaus

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Cooper Co (COO) with...

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Cooper Co (COO)

Cooper Companies (COO) has disclosed a new risk, in the Accounting & Financial Operations category. Cooper Companies appears to acknowledge that it...

Cooper Companies’ Risk Profile: Stable Disclosures But Ongoing Exposure for Investors

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immunic (IMUX), Celldex (CLDX) and Cooper Co (COO) w...

Analysts Are Bullish on These Healthcare Stocks: Immunic (IMUX), Celldex (CLDX)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Telix Pharmaceuticals (TLPPF) and Cooper Co (COO)....

Analysts Conflicted on These Healthcare Names: Telix Pharmaceuticals (OtherTLPPF) and Cooper Co (COO)

U.S. stocks finished Friday mixed after a stronger-than-expected August jobs report pushed Treasury yields higher and revived concerns that the Fed...

The Week That Was, The Week Ahead: Macro and Markets, September 6

Ostrom Climate Solutions Inc ( ($TSE:COO) ) just unveiled an update. Ostrom Climate Solutions reported Q2 2026 revenue of $550,084, down from $860,...

Ostrom Climate Narrows Loss and Returns to H1 Profit as It Pivots to Compliance-Focused Carbon Projects

Australian Oilseeds Holdings ( ($COOT) ) just unveiled an announcement. Australian Oilseeds Holdings Limited disclosed that it previously entered i...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	COO	$55.58	+0.36%	1.48M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	COO	$55.58	+0.4%	1.48M
3
4
5
6

COO

Get The Cooper Companies, Inc. Data in Excel

Get The Cooper Companies, Inc. Data in Excel